Prognostic value of microRNAs in gastric cancer: a meta-analysis.

BACKGROUND Previous articles have reported that expression levels of microRNAs (miRNAs) are associated with survival time of patients with gastric cancer (GC). A systematic review and meta-analysis was performed to study the outcome of it. DESIGN Meta-analysis. METHODS English studies estimating expression levels of miRNAs with any of survival curves in GC were identified up till March 19, 2017 through performing online searches in PubMed, EMBASE, Web of Science and Cochrane Database of Systematic Reviews by two authors independently. The pooled hazard ratios (HR) with 95% confidence intervals (CI) were used to estimate the correlation between miRNA expression and overall survival (OS). RESULTS Sixty-nine relevant articles about 26 miRNAs with 6148 patients were ultimately included. GC patients with high expression of miR-20b (HR=2.38, 95%CI=1.16-4.87), 21 (HR=1.77, 95%CI=1.01-3.08), 106b (HR=1.84, 95%CI=1.15-2.94), 196a (HR=2.66, 95%CI=1.94-3.63), 196b (HR=1.67, 95%CI=1.38-2.02), 214 (HR=1.84, 95%CI=1.27-2.67) or low expression of miR-125a (HR=2.06, 95%CI=1.26-3.37), 137 (HR=3.21, 95%CI=1.68-6.13), 141 (HR=2.47, 95%CI=1.34-4.56), 145 (HR=1.62, 95%CI=1.07-2.46), 146a (HR=2.60, 95%CI=1.63-4.13), 206 (HR=2.85, 95%CI=1.73-4.70), 218 (HR=2.61, 95%CI=1.74-3.92), 451 (HR=1.73, 95%CI=1.19-2.52), 486-5p (HR=2.45, 95%CI=1.65-3.65), 506 (HR=2.07, 95%CI=1.33-3.23) have significantly poor OS (P<0.05). CONCLUSIONS In summary, miR-20b, 21, 106b, 125a, 137, 141, 145, 146a, 196a, 196b, 206, 214, 218, 451, 486-5p and 506 demonstrate significantly prognostic value. Among them, miR-20b, 125a, 137, 141, 146a, 196a, 206, 218, 486-5p and 506 are strong biomarkers of prognosis in GC.

[1]  Q. Wu,et al.  MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1 , 2014, Cell Death and Disease.

[2]  Juan Zhao,et al.  MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. , 2015, International journal of clinical and experimental pathology.

[3]  Yue Xu,et al.  Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer , 2015, Growth factors.

[4]  P. Zhu,et al.  MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2 , 2015, Cellular Physiology and Biochemistry.

[5]  Xiaofeng Yu,et al.  The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival. , 2015, International journal of clinical and experimental medicine.

[6]  W. Mai,et al.  MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET. , 2015, Molecular medicine reports.

[7]  J. Sui,et al.  Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression , 2017, Clinical and Translational Oncology.

[8]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[9]  N. Tanaka,et al.  Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer , 2013, PloS one.

[10]  H. Liu,et al.  miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells , 2016, Tumor Biology.

[11]  Peng-fei Zhang,et al.  miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression , 2016, Oncotarget.

[12]  Chao Zhang,et al.  Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer , 2013, European journal of gastroenterology & hepatology.

[13]  Wei-Guo Zhu,et al.  Prognostic value of microRNA-126 and CRK expression in gastric cancer , 2016, OncoTargets and therapy.

[14]  Fang Wang,et al.  MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells , 2013, Journal of Cell Science.

[15]  Yang Xu,et al.  MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B , 2016, Oncotarget.

[16]  Dan Yan,et al.  MicroRNA-183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi-1 , 2014, Oncology letters.

[17]  Hsiang-Cheng Chi,et al.  Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. , 2016, European journal of cancer.

[18]  Feng Yang,et al.  Long non‐coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c‐Myc mRNA stability , 2014, The FEBS journal.

[19]  X. L. Wang,et al.  miR-218 tissue expression level is associated with aggressive progression of gastric cancer. , 2016, Genetics and molecular research : GMR.

[20]  Z. Li,et al.  Anti-proliferative role and prognostic implication of miR-141 in gastric cancer. , 2016, American journal of translational research.

[21]  Wei Zhang,et al.  microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer , 2015, Oncotarget.

[22]  Wei Wu,et al.  MicroRNA-873 inhibits proliferation and induces apoptosis by targeting CXCL 1 in gastric cancer , 2016 .

[23]  Qingchuan Zhao,et al.  Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival , 2014, PloS one.

[24]  Menghong Sun,et al.  MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer , 2015, Oncotarget.

[25]  Tao-Tao Liu,et al.  MicroRNA‐18a modulates P53 expression by targeting IRF2 in gastric cancer patients , 2016, Journal of gastroenterology and hepatology.

[26]  Jia Chen,et al.  miR-135a promotes gastric cancer progression and resistance to oxaliplatin , 2016, Oncotarget.

[27]  Ming Sun,et al.  Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression , 2014, Journal of Hematology & Oncology.

[28]  Wenhui Zhang,et al.  MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression , 2017, Journal of Experimental & Clinical Cancer Research.

[29]  R. Liu,et al.  miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer , 2014, Journal of cellular biochemistry.

[30]  Z. Jie,et al.  MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression. , 2015, American journal of cancer research.

[31]  Yao Lin,et al.  miR-183 inhibits invasion of gastric cancer by targeting Ezrin. , 2014, International journal of clinical and experimental pathology.

[32]  Ming Sun,et al.  Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a , 2014, Oncotarget.

[33]  Chuanli Ren,et al.  Expression and prognostic value of miR-92a in patients with gastric cancer , 2016, Tumor Biology.

[34]  Hao Liu,et al.  MicroRNA-217 in plasma : a potential biomarker in gastric cancer , 2017 .

[35]  Zhiyong Zhang,et al.  The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer , 2015, Oncotarget.

[36]  R. Kučera,et al.  Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy. , 2016, International journal of oncology.

[37]  Tengteng Zhang,et al.  MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1. , 2015, International journal of clinical and experimental pathology.

[38]  Qiu-lin Tang,et al.  Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. , 2014, Oncology reports.

[39]  Z. Ye,et al.  Abnormal expression of miR‐301a in gastric cancer associated with progression and poor prognosis , 2013, Journal of surgical oncology.

[40]  Xiang-Yu Luo,et al.  Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer , 2016, Cellular Physiology and Biochemistry.

[41]  Sheng Tan,et al.  MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression. , 2017, Pathology, research and practice.

[42]  Wei-wei Yu,et al.  miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3 , 2015, Oncology reports.

[43]  Chuanli Ren,et al.  High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer , 2016, Journal of Cancer Research and Clinical Oncology.

[44]  T. Okumura,et al.  MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. , 2011, Oncology letters.

[45]  Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer , 2017, Cancer Cell International.

[46]  Zhong Liu,et al.  Long non-coding RNA expression profile in human gastric cancer and its clinical significances , 2013, Journal of Translational Medicine.

[47]  Ying Wang,et al.  miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer. , 2015, The American journal of pathology.

[48]  Ying Zan,et al.  Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy , 2015, Chinese medical journal.

[49]  P. Gao,et al.  Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour , 2014, PloS one.

[50]  Jie Chen,et al.  Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer. , 2015, Cancer research.

[51]  K. Yanagihara,et al.  MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer. , 2014, Oncology reports.

[52]  Y. Toiyama,et al.  Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer , 2016, Gastric Cancer.

[53]  Xiaoshan Feng,et al.  Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis. , 2014, World journal of gastroenterology.

[54]  Chi Zhang,et al.  MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC , 2015, Iranian journal of basic medical sciences.

[55]  Xin-jian Lin,et al.  MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling , 2015, Oncotarget.

[56]  Q. Ma,et al.  MicroRNA-19b inhibits proliferation of gastric cancer cells by targeting B-cell CLL/lymphoma 3. , 2016, Oncology reports.

[57]  Min Deng,et al.  miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression , 2013, Clinical Cancer Research.

[58]  Baorui Liu,et al.  MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis , 2012, Medical Oncology.

[59]  K. Mimori,et al.  Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. , 2015, Carcinogenesis.

[60]  K. Mimori,et al.  Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases , 2012, British Journal of Cancer.

[61]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[62]  Jun Chen,et al.  MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1 , 2015, Tumor Biology.

[63]  J. Ahn,et al.  MiR 21‐5p as a predictor of recurrence in young gastric cancer patients , 2016, Journal of gastroenterology and hepatology.

[64]  Jong-Lyul Park,et al.  ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer , 2015, Genomics & informatics.

[65]  Chaoyang Xu,et al.  MiR-449c inhibits gastric carcinoma growth. , 2015, Life sciences.

[66]  Ming Sun,et al.  MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1 , 2012, Molecular Cancer Therapeutics.

[67]  Bo Zhou,et al.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN , 2013, Cancer Cell International.

[68]  K. Mimori,et al.  MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab , 2011, Clinical Cancer Research.

[69]  Y. Fan,et al.  MiR-215/192 participates in gastric cancer progression , 2014, Clinical and Translational Oncology.

[70]  Min Deng,et al.  miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer , 2013, PloS one.

[71]  Xiang-Yu Guo,et al.  Prognostic Value of microRNA Signature in Patients with Gastric Cancers , 2017, Scientific Reports.

[72]  K. Yanagihara,et al.  MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer , 2014, Cancer science.

[73]  P. Muti,et al.  miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer , 2012, Cell Death and Disease.

[74]  Meng Ding,et al.  MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer. , 2016, International journal of oncology.

[75]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[76]  Juan Li,et al.  MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1 , 2015, Oncotarget.

[77]  Zongguang Zhou,et al.  miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. , 2017, Cancer letters.

[78]  P. Liu,et al.  Decreased miR-452 expression and its tumor suppressive function in human gastric cancer , 2016 .

[79]  Xiao-mei Mo,et al.  Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer. , 2016, European review for medical and pharmacological sciences.

[80]  Yuhuang Li,et al.  miR‐494 acts as an anti‐oncogene in gastric carcinoma by targeting c‐myc , 2014, Journal of gastroenterology and hepatology.

[81]  Xinke Zhou,et al.  Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients , 2015, Drug design, development and therapy.

[82]  Angélica Figueroa,et al.  Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer , 2012, Journal of Translational Medicine.

[83]  Y-L Zhao,et al.  MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail , 2015, Cell Death and Disease.

[84]  Qi Zhou,et al.  Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin , 2011, PloS one.

[85]  Qiang Zhang,et al.  miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer , 2012, Gastroenterology research and practice.

[86]  Jie Xu,et al.  Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. , 2014, Cancer research.

[87]  Nitzan Rosenfeld,et al.  MicroRNAs as a potential prognostic factor in gastric cancer. , 2010, World journal of gastroenterology.

[88]  Qiurong Ruan,et al.  miR-125a regulates angiogenesis of gastric cancer by targeting vascular endothelial growth factor A. , 2015, International journal of oncology.

[89]  Jian Li,et al.  miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. , 2010, Biological & pharmaceutical bulletin.

[90]  S. Choi,et al.  NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal , 2015, Oncotarget.

[91]  G. Jin,et al.  miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value , 2016, Oncotarget.

[92]  Wei Zhao,et al.  MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2. , 2016, Oncology reports.

[93]  F. Liu,et al.  miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer , 2015, BioMed research international.

[94]  S. Choi,et al.  Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. , 2013, World journal of gastroenterology.

[95]  Yuan Yuan,et al.  miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway , 2016, OncoTargets and therapy.

[96]  Bo Zhou,et al.  MicroRNA‐106b in cancer‐associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN , 2014, FEBS letters.

[97]  Jia Liu,et al.  Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer , 2016, Journal of Experimental & Clinical Cancer Research.

[98]  Y. Shang,et al.  miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 , 2015, Cell Death and Disease.

[99]  C. Zhang,et al.  PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis , 2016, Journal of Molecular Medicine.

[100]  Xue-mei Ma,et al.  Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis , 2013, Oncology letters.

[101]  T. Hibi,et al.  CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence , 2013, British Journal of Cancer.

[102]  Bing‐Xia Zhou,et al.  Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer. , 2014, International journal of clinical and experimental pathology.

[103]  Hongwei Zhang,et al.  MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation , 2015, Journal of Cancer Research and Clinical Oncology.

[104]  Weidong Yu,et al.  Association of microRNA-181c expression with the progression and prognosis of human gastric carcinoma. , 2013, Hepato-gastroenterology.

[105]  Peng Li,et al.  MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers , 2015, Oncotarget.

[106]  Y. Y. Lu,et al.  Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer. , 2016, Genetics and molecular research : GMR.

[107]  Guifeng Liu,et al.  Increased microRNA-223 in Helicobacter pylori-associated gastric cancer contributed to cancer cell proliferation and migration , 2014, Bioscience, biotechnology, and biochemistry.

[108]  Jun Yu,et al.  MicroRNA dysregulation in gastric cancer: a new player enters the game , 2010, Oncogene.

[109]  K. Mimori,et al.  Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. , 2012, International journal of oncology.

[110]  Hongwei Zhang,et al.  miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.

[111]  Chuanli Ren,et al.  Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma , 2015, PloS one.

[112]  Y. Xin,et al.  RETRACTED ARTICLE: Impairment of growth of gastric carcinoma by miR-133-mediated Her-2 inhibition , 2015, Tumor Biology.

[113]  Jun Zhang,et al.  Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy , 2015, PloS one.

[114]  Kazuhiro Yoshida,et al.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. , 2010, The Lancet. Oncology.

[115]  Guoqing Wang,et al.  Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2 , 2016, Oncotarget.

[116]  Xiaohua Li,et al.  MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer , 2011, Journal of cellular and molecular medicine.

[117]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[118]  Ji-Liang Li,et al.  hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a , 2016, Scientific Reports.

[119]  Y. Zhuang,et al.  MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival , 2014, Oncogene.

[120]  Jianguo G. Wu,et al.  MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis , 2015, Gastric Cancer.

[121]  H. Iinuma,et al.  Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. , 2012, Oncology reports.

[122]  Dan Li,et al.  miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14 , 2016, Oncotarget.

[123]  Cong Li,et al.  MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2. , 2017, Oncology reports.

[124]  Y. Zhang,et al.  Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. , 2016, European review for medical and pharmacological sciences.

[125]  Zhenggang Zhu,et al.  Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer , 2014, Oncotarget.

[126]  Huijie Xiao,et al.  The up-regulation of miR-300 in gastric cancer and its effects on cells malignancy. , 2015, International journal of clinical and experimental medicine.

[127]  Wei-Guo Zhu,et al.  Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[128]  D. Ichikawa,et al.  Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. , 2013, Anticancer research.

[129]  Xin Zheng,et al.  Decreased miR-198 expression and its prognostic significance in human gastric cancer , 2016, World Journal of Surgical Oncology.

[130]  Y. Tu,et al.  Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis , 2013, Diagnostic Pathology.

[131]  Yanshu Li,et al.  miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. , 2014, Cellular signalling.

[132]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[133]  Wenbo Tang,et al.  MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer , 2016, Oncotarget.

[134]  Q. Ma,et al.  MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7 , 2015, Tumor Biology.

[135]  C. Fan,et al.  Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance , 2012, The Journal of international medical research.

[136]  Gang Ma,et al.  Expression of microRNA-211 is a novel prognostic indicator of poor survival in human gastric cancer , 2016 .

[137]  Z. Rehman,et al.  Antisense therapeutics in oncology: current status , 2014, OncoTargets and therapy.

[138]  Liduan Zheng,et al.  miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression , 2016, Cell Death and Disease.

[139]  Zihua Chen,et al.  MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression , 2014, Molecular and Cellular Biochemistry.

[140]  Shu Wu,et al.  MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis , 2015, Oncotarget.

[141]  Si-hai Liu,et al.  Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer , 2014, Medical Oncology.

[142]  Shengjun Xiao,et al.  MicroRNA-146a affects the chemotherapeutic sensitivity and prognosis of advanced gastric cancer through the regulation of LIN52 , 2016, Oncology letters.

[143]  Jin-hai Tang,et al.  MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes. , 2015, Oncology reports.

[144]  S. Choi,et al.  Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. , 2013 .

[145]  Jun Zhang,et al.  Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[146]  Taicheng Zhou,et al.  MicroRNA‐520c enhances cell proliferation, migration, and invasion by suppressing IRF2 in gastric cancer , 2016, FEBS open bio.

[147]  Jackeline Agorreta,et al.  microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells , 2009, Clinical Cancer Research.

[148]  X. Che,et al.  MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion , 2015, OncoTargets and therapy.

[149]  K. Mimori,et al.  Clinical Significance of miR-146a in Gastric Cancer Cases , 2011, Clinical Cancer Research.

[150]  Z. Tian,et al.  Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44 , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[151]  Huihuan Tang,et al.  Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas. , 2012, Acta gastro-enterologica Belgica.

[152]  Li-de Tao,et al.  Oncotargets and Therapy Dovepress Dovepress Mir-20b Overexpression Is Predictive of Poor Prognosis in Gastric Cancer , 2022 .

[153]  Zhenggang Zhu,et al.  microrna expression signature of gastric cancer cells relative to normal gastric mucosa. , 2012, Molecular medicine reports.

[154]  L. Gu,et al.  miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C , 2016, Tumor Biology.

[155]  Yimin Xiong,et al.  Identification of hsa-miR-335 as a Prognostic Signature in Gastric Cancer , 2012, PloS one.

[156]  Yanong Wang,et al.  The expression and clinical significance of miR-132 in gastric cancer patients , 2014, Diagnostic Pathology.

[157]  H. Qian,et al.  Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. , 2012, Molecular medicine reports.

[158]  Guoqiang Zhao,et al.  miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells , 2015, Tumor Biology.

[159]  K. Yanagihara,et al.  MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis , 2014, Cancer science.

[160]  Cheng‐Yi Chen,et al.  MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. , 2014, Cancer letters.

[161]  Jie Yu,et al.  Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker , 2016, OncoTargets and therapy.

[162]  Y. Fujii,et al.  microRNA expression profile in undifferentiated gastric cancer. , 2009, International journal of oncology.

[163]  D. Fan,et al.  MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor , 2010, PLoS genetics.

[164]  X. Chen,et al.  Prognostic value of miR-141 downregulation in gastric cancer. , 2015, Genetics and molecular research : GMR.

[165]  Y. Shang,et al.  miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1 , 2014, Oncogene.

[166]  D. Xie,et al.  Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway , 2017, Molecular Cancer.

[167]  Ming Sun,et al.  Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer , 2014, BMC Cancer.

[168]  Tong Liu,et al.  Correlation between microRNA-421 expression level and prognosis of gastric cancer. , 2015, International journal of clinical and experimental pathology.

[169]  S-J Li,et al.  Serum miR-200 c expression level as a prognostic biomarker for gastric cancer , 2015 .

[170]  X. Su,et al.  Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.